Vimarsana
Biggest News Aggregation in the World

Page 2 - Standard Deviation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Standard Deviation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Standard Deviation Today - Breaking & Trending Today

Critical Values Statistics: Exploring Critical Values in Statistical Analysis - Vimarsana News

Critical Values Statistics: Exploring Critical Values in Statistical Analysis

Learn about critical values in statistics: key benchmarks determining significance levels and guiding statistical analysis........

Matthew Nudy, MD: Balancing the Benefits and Risk of Intensive Blood Pressure Control - Vimarsana News

Matthew Nudy, MD: Balancing the Benefits and Risk of Intensive Blood Pressure Control

Matthew Nudy, MD, discusses a trio of meta-analyses examining the effects of intensive blood pressure control on various targets.

Catheter Ablation for AFib Shows Little to No Benefit in HFpEF, Despite Positive Effect in HFrEF - Vimarsana News

Catheter Ablation for AFib Shows Little to No Benefit in HFpEF, Despite Positive Effect in HFrEF

A meta-analysis of 12 trials suggests catheter ablation for atrial fibrillation reduces heart failure events in HFrEF patients but not in HFpEF.

SGLT2 Inhibitors Reduce Risk of New Gout Diagnoses in T2D Relative to Sulfonylurea - Vimarsana News

SGLT2 Inhibitors Reduce Risk of New Gout Diagnoses in T2D Relative to Sulfonylurea

A propensity score-matched, new-user analysis suggests SGLT2 inhibitors may reduce gout risk in type 2 diabetes patients relative to other second-line therapies.

Web App Could Improve Statin Therapy Without Need for Clincian Prescription - Vimarsana News

Web App Could Improve Statin Therapy Without Need for Clincian Prescription

A study on a web app for nonprescription statin therapy shows high concordance with clinician assessment, with 84.5% of participants achieving LDL-C reduction of 20% or more.